Hemodynamics During Cesarean Delivery Under Spinal Anesthesia With Norepinephrine Versus Ephedrine
Recruiting
Phase 4
Interventional Study
Cesarean Delivery
Spinal Anesthesia for Cesarean Section
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 19 – 40
- Sex
- Female
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 200 (estimated)
- Sponsor
- Mansoura University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Echocardiography will be used to measure cardiac output and calculate other important hemodynamic variables in healthy patients with full-term singleton pregnancy during cesarean delivery under conventional spinal anesthesia using 2 different vasopressor drugs: norepinephrine in 1 group versus ephedrine in another group.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* American Society of Anesthesiologists physical status II.
* Singleton, full term pregnancy.
* Scheduled cesarean delivery under spinal anesthesia.
Exclusion Criteria:
* Height \<150 or \>180 cm.
* Weight \<60 or \>110 kg.
* Body mass index (BMI) \<18.5 or ≥35 kg/m².
* Women …
Contacts